AR023548A1 - Derivados de 2-alcoxi-ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica - Google Patents

Derivados de 2-alcoxi-ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica

Info

Publication number
AR023548A1
AR023548A1 ARP000101828A ARP000101828A AR023548A1 AR 023548 A1 AR023548 A1 AR 023548A1 AR P000101828 A ARP000101828 A AR P000101828A AR P000101828 A ARP000101828 A AR P000101828A AR 023548 A1 AR023548 A1 AR 023548A1
Authority
AR
Argentina
Prior art keywords
ciclobuten
alcoxi
diona
therapeutics
derivatives
Prior art date
Application number
ARP000101828A
Other languages
English (en)
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of AR023548A1 publication Critical patent/AR023548A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Los compuestos responden a la formula general (1) en la cual: R1 y R2 representan, independientemente entre sí, un átomo de hidrogeno o un grupo alquiloC1-3; R3 representa un átomo de hidrogeno o un grupo alquilo C1-6; W representa un grupo OR4; y R4representa un grupo alquilo C1-10, alquenilo C2-6, alquiniloC2-6, cicloalquilo C3-6-alquilo C1-3, bencilo, o fluoroalquilo C1-6. Aplicacion en terapéutica.
ARP000101828A 1999-04-20 2000-04-19 Derivados de 2-alcoxi-ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica AR023548A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9904945A FR2792634B1 (fr) 1999-04-20 1999-04-20 Derives de 2-alcoxy-cyclobutene-3,4-dione leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
AR023548A1 true AR023548A1 (es) 2002-09-04

Family

ID=9544620

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000101828A AR023548A1 (es) 1999-04-20 2000-04-19 Derivados de 2-alcoxi-ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica

Country Status (6)

Country Link
AR (1) AR023548A1 (es)
AU (1) AU3971800A (es)
CO (1) CO5160305A1 (es)
FR (1) FR2792634B1 (es)
UY (1) UY26110A1 (es)
WO (1) WO2000063160A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495576B2 (en) 2001-02-07 2002-12-17 Abbott Laboratories Aminal diones as potassium channel openers
DE10135815A1 (de) * 2001-07-23 2003-02-06 Bayer Ag Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen
US20050107394A1 (en) * 2001-12-17 2005-05-19 Ardeschir Ghofrani Novel use of selective pde5 inhibitors
FR2842271B1 (fr) 2002-07-15 2004-09-10 Eurocopter France Boite de transmissiion de puissance basculante a transfert de charge par le carter

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9311282D0 (en) * 1993-06-01 1993-07-21 Rhone Poulenc Rorer Ltd New compositions of matter

Also Published As

Publication number Publication date
CO5160305A1 (es) 2002-05-30
FR2792634B1 (fr) 2001-06-01
WO2000063160A1 (fr) 2000-10-26
FR2792634A1 (fr) 2000-10-27
UY26110A1 (es) 2000-12-29
AU3971800A (en) 2000-11-02

Similar Documents

Publication Publication Date Title
FI93831B (fi) Tetratsolit, jotka ovat verenpainetta alentavien yhdisteiden välituotteita
TR200201874T2 (tr) Proteaz inhibitörleri olarak yeni bileşikler ve bileşimler.
EE9900217A (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
ES2189235T3 (es) 6-fenilfenantridinas sustituidas.
TR200102338T2 (tr) Siklik ikame edilmiş bağlı pirolokarbazoller ve izoindolonlar.
PA8467101A1 (es) Compuestos 4-(2-ceto-1-benzilimidazolinil)piperidina como agonistas del receptor orli
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
PT1007523E (pt) Derivados indole e 2,3-di-ridroindole, sua preparacao e utilizacao
SE9904508D0 (sv) New compounds
TR199900486T2 (xx) Aziniloksi ve fenoksi-diaril-karbonasit t�revleri.
ATE332903T1 (de) Kondensierte pyridoindolderivate
BR9910908A (pt) Indenopirrolocarbazóis ligados em ponte
MA27501A1 (fr) Derives d'imidazoquinoline en tant que ligands recepteurs de l'adenosine a3
BR0007864A (pt) Composto, e, uso de um composto
IT1255802B (it) Derivati imidazolici ad attivita' a ii antagonista
DK1189900T3 (da) Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler
CY1105591T1 (el) Αναστολεις για συνθαση του 20-ηετε
BR9809848A (pt) Composição
DE60112960D1 (de) Kondensierte pyridoindolderivate
IS2143B (is) Píperasínómetýlbensamíð sem delta-ópíóíðviðtakagerandefni
BR9714215A (pt) Derivados de benzoato de 1,4-diazabiciclo[2.2.2]oct-2-ilmetila, seu preparo e sua aplicação em terapêutica
DE60121587D1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
AR023548A1 (es) Derivados de 2-alcoxi-ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica
TR199802552T2 (xx) 5-HT-2C Resept�r kar��tlar� olarak faydal� indolin t�revleri.
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende